Mabion Biologics at PCI Days 2026

• PCI Days is an outstanding forum for business networking and exploring the latest technological innovations. The event serves as a platform for strengthening our team’s expertise and broadening the range of capabilities we can offer our partners.
• We had many promising discussions that we believe will pave the way for future business cooperation.

Key Discussions with Technology Partners at PCI Days

PCI Days 2026 is the largest trade fair for the pharmaceutical industry in Central and Eastern Europe. Our industry is all about continuous risk and quality management. To stay ahead of technological trends, we are constantly seeking the best solutions for our projects. This year, Mabion sent a group of specialists from the Manufacturing, Maintenance and Quality Control Departments. Discussions with a wide range of technology providers focused on expanding our operational capabilities. Thanks to networking, we were able to build new, valuable business relationships.

At PCI Days 2026, the Mabion Biologics team was visible not only in conversations and networking. Our star performer was Amanda Jabłońska, Head of the Physicochemical and Biological Analysis Department. On the main pharmaceutical stage, she showcased the operational maturity of our organization. In her talk, “Organizational Readiness for LIMS: The Price of Digitalization and the Loss of Flexibility“, she discussed how Laboratory Information Management Systems facilitates planning, coordination, and oversight of activities within our laboratories.

The implementation of the LIMS system at Mabion has significantly enhanced the automation of our laboratory operations. As a result, we observed substantial improvements in both productivity and operational efficiency. LIMS has also greatly facilitated the execution of integrated analytics. In addition, the system enables the early identification of potential issues during process development. This helps reduce the likelihood of errors and minimizes operational risk. These capabilities are highly valued by our partners. They represent a key differentiator for clients seeking a reliable and efficient laboratory partner.

Prepared by:

Jakub Knurek

Marketing Specialist

j.knurek@mabion.eu

Jakub Knurek

Marketing Specialist

Jakub Knurek is a marketing and business development expert specializing in CDMO operations with scientific and biopharmaceutical background. During the COVID-19 pandemic, he contributed to the development of the Novavax protein vaccine. As a side project, he runs his own pharma company.

As the author of numerous articles, he is recognized as an important voice of the younger generation of scientists. He is a member of Mabion’s representation at industry trade shows, including BIO International Convention 2025 in Boston, 2nd Global Biologics India 2025 in Hydrabad, CPHI 2024 in Milan, CPHI 2023 in Barcelona, Life Sciences Baltics 2023 in Vilnius. He actively participates in academic, business and industry discussions, such as the “Building the Future Pharma Workforce” panel at CPHI Milan 2024.